Private Wealth Management Group, LLC
Position in ROIV — Roivant Sciences Ltd.
CIK 2011342
PRINCETON, NJ
Position in ROIV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$15,076
+$3,276 QoQ
Shares Held
426
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#404
of 494 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Private Wealth Management Group, LLC holds $380,601 across 51 Biotechnology names. ROIV ranks #11 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
60 | $37,412 | |
| 2 | INCY |
Incyte Corp
|
225 | $25,506 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
123 | $23,035 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
55 | $20,441 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
40 | $19,869 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
62 | $18,663 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
206 | $16,791 | |
| 8 | EXEL |
Exelixis, Inc.
|
287 | $15,615 |
All Filings in ROIV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,076 | 426 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $11,800 | 426 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $9,244 | 426 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $6,445 | 426 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $4,801 | 426 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $4,409 | 437 | Shares | Sole | 2025-05-02 | |
| No filing history on record for this holder in this stock. | ||||||